Out-licensing: Low Dose Estradiol/Progestin Tablets (Cliovelle)

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders.

Hormone replacement.

Cliovelle - a low dose Estradiol/Progestin oral combination product for treatment of menopausal disorders (HRT)

Registered

N/A

Licensing opportunities worldwide, excluding Germany, Poland, Scandinavia, Czech Republic and Slovakia

Dr Andre Toussaint
Director, Int. & Corp. Development

Dr. Kade Pharmazeutische Fabrik GmbH

Fully integrated pharmaceutical company.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.